SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

Retail success attributed to filling unmet needs with science-driven, consumer-friendly solutions and loyal customer ...

The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

Agricultural production is declining at an increasing rate due to the effects of climate change, including water, salt, and ...

Ukraine emerged from the January 6 summit of the Coalition of the Willing in Paris not with another vague assurance, but with ...

From policy to practice, Kenya’s updated biodiversity strategy shows how countries can align national action with the Global ...

Sri Lanka’s economic recovery is threatened not only by past crises, but by a growing governance vacuum in how financial ...

Key recommendations in the report, which was delayed after a deadly July fire in Fall River, include fire safety and ...

Helping to reduce the life-cycle greenhouse gas emissions from aviation by up to 80% when used neat, SAF could be ...